Hargadon et al. demonstrated that murine melanoma tumour derived antigen can be cross-presented by APCs or directly presented by tumour cells to naïve T cells in TDLN, and that this induces CD8+ T cell differentiation (Hargadon et al., 2006). This evidence concerns the gene CD8A and melanoma.